Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Metoprolol tartrate matrix sustained-release tablet

A technology of metoprolol tartrate and matrix sustained-release material, which is applied to sugar-coated pills, pill delivery, endocrine system diseases, etc. Low cost and technically simple effect

Active Publication Date: 2014-04-02
北京天衡药物研究院有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0020] It can be seen from Fig. 1 in vitro release curve in this article that the drug release is basically constant at 0-10 hours, and the release rate is about 0.052 / h. However, at 10-12 hours, the drug release is less than 5%, and the drug release rate is less than 0.025 / h. obvious downward trend
[0022] In addition, the compression of the three-layer tablet requires the use of a three-layer tablet press, and its process is cumbersome. At present, there are few three-layer tablet presses that can be used for industrial production at home and abroad. In the article, S.M.Al-Saidan et al. use a single-layer tablet press The three-layer tablet is compressed manually by the machine, and the compression force between the layers and the compressed density significantly affect the release of the drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Metoprolol tartrate matrix sustained-release tablet
  • Metoprolol tartrate matrix sustained-release tablet
  • Metoprolol tartrate matrix sustained-release tablet

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0076] Embodiment 1 metoprolol tartrate contains the double-layer tablet of control layer

[0077] 1) Prescription composition

[0078] drug layer

[0079] Composition Dosage (1000 tablets)

[0080] Metoprolol Tartrate 25

[0081] Hypromellose K4M 70

[0082]Hypromellose K15M 50

[0083] Micronized silica gel 50

[0084] Stearic acid 30

[0085] 10% PVP k30 85% ethanol appropriate amount

[0086] Magnesium Stearate 3

[0087] Regulatory layer

[0088] Composition Dosage (1000 tablets)

[0089] Hypromellose K4M 35

[0090] Micronized silica gel 20

[0091] Stearic acid 15

[0092] 10% PVP k30 85% ethanol appropriate amount

[0093] Magnesium Stearate 2

[0094] 2) Preparation process:

[0095] Drug layer:

[0096] 1. Take the prescribed amount of metoprolol tartrate, hypromellose K4M, hypromellose K15M, micropowder silica gel and stearic acid and mix evenly;

[0097] 2. 10% PVP k30 85% ethanol solution...

Embodiment 2

[0112] Embodiment 2 Metoprolol tartrate contains the double-layer tablet and single-layer tablet contrast of control layer

[0113] Prescription: See Table 8 below

[0114] Preparation process: with embodiment 1

[0115] According to the United States Pharmacopoeia USP30 Metoprolol Succinate Sustained-release Tablet Standard, the release results are shown in Table 9 below, and all data are the average values ​​of 6 samples from the same batch.

[0116] Table 8 Example 2 prescription

[0117]

[0118] *(Klucel MF)

[0119] ▲(Klucel HF)

[0120] ◆(kollicoat SR)

[0121] ★Adhesive: 10% PVP K30 85% ethanol solution

[0122] Table 9 release results

[0123]

[0124] In this example, the comparison between the double-layer tablet containing metoprolol tartrate containing the regulating layer and the traditional single-layer tablet shows that on the basis of the single-layer tablet that releases too fast in the early stage, adding an appropriate regulating layer can obtai...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention provides a novel metoprolol tartrate-containing matrix sustained-release tablet, i.e. a metoprolol tartrate matrix sustained-release tablet with a regulation layer. The novel double-layer matrix sustained-release tablet with the regulation layer is prepared by adding the regulation layer on the basis of the traditional metoprolol tartrate matrix sustained-release tablet, can release medicines uniformly in 24 hours, overcomes the defects of the metoprolol tartrate sustained-release tablet in the prior art, and has the advantages of ideal release effect, simple process and low cost.

Description

technical field [0001] The invention relates to a novel matrix sustained-release tablet containing metoprolol tartrate, in particular to a metoprolol tartrate matrix sustained-release tablet with a regulating layer, which can be sustained-release for 24 hours. Background technique [0002] Metoprolol is a β1-receptor blocker without partial agonist activity (cardioselective β-receptor blocker), used for the treatment of hypertension, angina pectoris, myocardial infarction, hypertrophic cardiomyopathy, main Arterial dissection, arrhythmia, hyperthyroidism, cardiac neurosis, etc., have also been found to be useful in the treatment of heart failure in recent years. [0003] Metoprolol itself has low solubility in water, which affects its bioavailability. Therefore, the metoprolol preparations currently on the market are mainly its salts, such as metoprolol tartrate, metoprolol succinate etc., the dosage forms include ordinary tablets, sustained-release tablets, controlled-rele...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/24A61K9/28A61K31/138A61P9/12A61P9/10A61P9/06A61P9/00A61P9/04A61P5/16
Inventor 姜庆伟梁希刘全志杨文斌
Owner 北京天衡药物研究院有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com